Abstract
To examine the value of individual and combinations of ovarian cancer associated blood biomarkers for the discrimination between plasma of patients with type I or II ovarian cancer and disease-free volunteers.
| Original language | English |
|---|---|
| Journal | Gynecologic Oncology |
| Volume | 122 |
| Issue number | 3 |
| Pages (from-to) | 560-6 |
| Number of pages | 7 |
| ISSN | 0090-8258 |
| DOIs | |
| Publication status | Published - 2011 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Antigens, Neoplasm
- Autoantibodies
- CA-125 Antigen
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Membrane Proteins
- Middle Aged
- Ovarian Neoplasms
- Tumor Markers, Biological
- Tumor Suppressor Protein p53
Fingerprint
Dive into the research topics of 'Comparison of candidate serologic markers for type I and type II ovarian cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS